Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DIVZ | 38.01 | 0.43 | +1.14% |
| Polen Dividend Income ETF (DIVZ) | |||
| FNX | 139.61 | 0.76 | +0.54% |
| First Trust Mid Cap Core AlphaDEX Fund (FNX) | |||
| SHUS | 50.89 | N/A | N/A |
| Stratified LargeCap Hedged ETF (SHUS) | |||
| TKNQ | 23.83 | -0.74 | -3.03% |
| Amplify Tokenization Technology Leaders ETF (TKNQ) | |||
| SSK | 13.99 | -0.65 | -4.44% |
| REX-Osprey SOL + Staking ETF (SSK) | |||
A.I.dvisor indicates that over the last year, APLM has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then SNTI could also see price increases.
| Ticker / NAME | Correlation To APLM | 1D Price Change % | ||
|---|---|---|---|---|
| APLM | 100% | -1.80% | ||
| SNTI - APLM | 47% Loosely correlated | -4.48% | ||
| HCWB - APLM | 45% Loosely correlated | -0.85% | ||
| PRAX - APLM | 39% Loosely correlated | -3.03% | ||
| MGX - APLM | 37% Loosely correlated | -0.30% | ||
| IPHA - APLM | 36% Loosely correlated | -0.63% | ||
More | ||||
Industry Biotechnology
The Aroon Indicator for APLM entered a downward trend on October 22, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 196 similar instances where the Aroon Indicator formed such a pattern. In 177 of the 196 cases the stock moved lower. This puts the odds of a downward move at 90%.
APLM moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for APLM crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where APLM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 63 cases where APLM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on APLM as a result. In 67 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for APLM just turned positive on October 22, 2026. Looking at past instances where APLM's MACD turned positive, the stock continued to rise in 27 of 47 cases over the following month. The odds of a continued upward trend are 57%.
Following a +8.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where APLM advanced for three days, in 137 of 173 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
APLM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. APLM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.121) is normal, around the industry mean (2.973). P/E Ratio (-1.485) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (3.761) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APLM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.